Video
Study investigates impact of genetics on post-RT GU toxicity in prostate cancer patients
Author(s):
“We wanted to see whether certain variations and these micro-RNA binding sites could be associated with the risk of developing side effects,” says Amar U. Kishan, MD.
Video Player is loading.
In this video, Amar U. Kishan, MD, discusses the background and methods of the study, “Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation.” Kishan is an associate professor in the department of radiation oncology, chief of genitourinary oncology service, and vice chair of clinical and translational research at the University of California, Los Angeles.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Sacral neuromodulation device empowers patients with greater UUI control
Howard Goldman, MD, on his experience with the Glean Urodynamics System
Study: Women with SCI are more likely to use indwelling catheters
Ziho Lee, MD, previews 2025 Northwestern GU robotic reconstruction course
Christine Ibilibor, MD, highlights study of racial differences in abiraterone use
Vikram Narayran, MD, on tech-driven changes that are enhancing patient care
Justin Dubin, MD, on leveraging digital tools to improve patient buy-in
Betty Wang, MD, and Laura Bukavina, MD, MPH, MSc, discuss ctDNA's role in NMIBC treatment decisions
Andrea Pezzella, MD, URPS, FACOG, discusses Neuspera's integrated sacral neuromodulation system
Mina Fam, MD, on managing expectations around testosterone replacement therapy
Related Content
